Clinical Trial

Endoscopic Cryoablation Combined With PD-1 in Advanced Gastric Cancer

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated April 29, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
To clarify the efficacy and safety of endoscopic cryoablation combined with PD-1 monoclonal antibody treatment regimen in advanced gastric cancer.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-12-28.
Trial Details
NCT Number NCT06759233
Lead Sponsor Zhongguang Luo, MD
Conditions Gastric Cancer
Enrollment 15 participants
Start Date 2025-05-15
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-29